BMPR2 and neoplasm: In summary, we identified, for the first time, that the tumor suppressor miRNA miR-100-3p directly targeted to BMPR2 and consequently regulated the ERK/AKT and Bax/Bcl2-Caspase3 signaling pathways in GC.